<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0240">
 <label>48</label>
 <element-citation publication-type="journal" id="h0240">
  <person-group person-group-type="author">
   <name>
    <surname>Loeb</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Dokainish</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Dans</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Palileo-Villanueva</surname>
    <given-names>L.M.</given-names>
   </name>
   <name>
    <surname>Roy</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Karaye</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design</article-title>
  <source>Am Heart J</source>
  <volume>212</volume>
  <year>2019</year>
  <fpage>36</fpage>
  <lpage>44</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ahj.2019.02.009</pub-id>
  <pub-id pub-id-type="pmid">30933856</pub-id>
 </element-citation>
</ref>
